Heart Health, Inc.

Heart Health, Inc.

February 18, 2009 08:30 ET

Heart Health, Inc. Files for U.S. Provisional Patent on Its Heart Health Monitor

MONTREAL, CANADA--(Marketwire - Feb. 18, 2009) - Heart Health, Inc. (PINK SHEETS:HHEL) is pleased to announce that the Company has filed a Provisional Patent application with the United States Patent and Trademark Office. A provisional application for the patent was filed in the USPTO on February 13, 2009 and the Company received confirmation of receipt for processing. A provisional patent provides the means to establish an early effective filing date in a later-filed non-provisional patent application. It also allows the term "Patent Pending" to be applied in connection with the description of the invention.

This provisional patent application focuses on the technology behind the inflation of the device to assure good contact with the skin and the electrodes used to capture the electronic data, which the device then interprets and displays in graphic form.

This application benefits the Company in three ways: (1) patentability will be evaluated as though it was filed on the earlier provisional application filing date, freezing out others with similar claims that have not yet filed, (2) the resulting patent will be treated as the earlier provisional application filing date, and (3) the twenty-year patent term will be measured from the later non-provisional application filing date.

"We are excited to have received our first patent pending status on the Heart Health Monitor as we enter the final stages of development. We expect to file additional patents on unique technology that we have developed in several components of our Heart Health Monitor," stated Michael Kron, Chairman and CEO of Heart Health, Inc.

About Heart Health, Inc.:

Heart Health, Inc. is a holding company focused on the development and marketing of innovative, cardiovascular medical device products. The Company intends to revolutionize the way in which people monitor the health of their hearts using newly acquired products, such as the Heart Health Monitor.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact Information